May 4, 2017 / 8:49 PM / 3 months ago

BRIEF-Veracyte announces pivotal clinical validation data

1 Min Read

May 4 (Reuters) - Veracyte Inc:

* Veracyte announces pivotal clinical validation data for next-generation afirma test to help more patients avoid unnecessary surgery in thyroid cancer diagnosis

* Veracyte Inc- will begin making afirma GSC available to select customers in next few weeks and plans to broaden commercial expansion throughout 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below